News

Researchers have successfully coaxed a deadly pathogen to destroy itself from the inside out. In the new study, researchers modified DNA from a bacteriophage or “phage,” a type of virus that infects and replicates inside of bacteria.

Protein-degrader drugs have shown promise, but resistance to these drugs is an unresolved issue. New research has made progress toward understanding and combating resistance.

Calcium ions are essential for cells, but can be toxic in higher concentrations. A team of researchers has now designed and prepared a combination drug that kills tumor cells by modulating the calcium influx into the cell.

In a new mouse study, researchers from the USC Stem Cell lab of Rong Lu describe how specific gene activity could potentially enhance immune cell production.

Five out of six children with a type of hereditary hearing loss have shown improvement in their hearing and speech recognition after treatment with an experimental gene therapy. This is the first gene therapy trial for children with this type of hearing loss.

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.

An anti-blood clotting drug that inhibits the coagulating protein factor XI may lower the risk of recurrent strokes, reports a phase II trial.

Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study offers hope that this could change in the medium term.

People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.

The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.